WAHIDUZZAMAN, M.; YASMIN, A.; SHAHRIAR HOSSAIN, M.; DHAR, R.; HAIDER, M. M. Efficacy and safety of empagliflozin (SGLT2 inhibitor) in Bangladeshi patients with type 2 diabetes mellitus. International Journal of Research in Medical Sciences, [S. l.], v. 13, n. 12, p. 5150–5154, 2025. DOI: 10.18203/2320-6012.ijrms20253934. Disponível em: https://www.msjonline.org/index.php/ijrms/article/view/15838. Acesso em: 2 feb. 2026.